French drug trial: one person 'brain dead' and five critical after test goes badly wrong
Volunteers taking a 'cannabis-based painkiller' hospitalised in what French health minister calls a 'very serious accident'
Six people are critically ill – with one said to be brain dead - following clinical trials in France for a new "cannabis-based painkiller".
Health minister Marisol Touraine said the volunteers had been taking oral medication in a drugs trial run by a private laboratory in Rennes when there was a "very serious accident".
The trial has been called off and all test subjects recalled for examination.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
According to the Daily Telegraph, one person involved is now "brain dead", though the BBC says only that the worst-affected victim is "in a coma".
Ouest France regional newspaper says the test was being carried out by the private laboratory Biotrial, which has 200 staff in France as well as offices in other parts of the world, including the UK and US.
While the type of drug being tested has not yet been confirmed, French media say it was a new analgesic that contains cannabis.
The accident comes almost ten years after a drugs trial in the UK went disastrously wrong. Six healthy young men suffered organ failure after taking the drug TGN1412 at Northwick Park hospital in London.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
The worst-affected, plumber Ryan Wilson, who lost toes and fingers, was awarded £2m compensation, as the Daily Mail reported at the time.
A report later said the company managing the trial, Parexel, had been unclear about a safe dose to start the subjects on and it should have tested the drug on one person at a time.
-
China’s burgeoning coffee cultureUnder The Radar Local chains are thriving as young middle-class consumers turn away from tea
-
Obamacare: Why premiums are rocketingFeature The rise is largely due to the Dec. 31 expiration of pandemic-era ‘enhanced’ premium subsidies, which are at the heart of the government shutdown
-
Ultra-processed AmericaFeature Highly processed foods make up most of our diet. Is that so bad?
-
Nigeria confused by Trump invasion threatSpeed Read Trump has claimed the country is persecuting Christians
-
The Louvre’s security measures are in hot water after a major heistIn the Spotlight Millions of dollars in jewels were stolen from the museum
-
France’s ‘red hands’ trial highlights alleged Russian disruption operationsUNDER THE RADAR Attacks on religious and cultural institutions around France have authorities worried about Moscow’s effort to sow chaos in one of Europe’s political centers
-
The WW2 massacre dividing Senegal and FranceUnder the Radar A new investigation found the 1944 Thiaroye attack on ‘unarmed’ African soldiers was ‘premeditated’, and far deadlier than previously recorded
-
Sanae Takaichi: Japan’s Iron Lady set to be the country’s first woman prime ministerIn the Spotlight Takaichi is a member of Japan’s conservative, nationalist Liberal Democratic Party
-
Prime minister shocks France with resignationSpeed Read French Prime Minister Sebastien Lecornu submitted his government’s resignation after less than a month in office
-
Russia is ‘helping China’ prepare for an invasion of TaiwanIn the Spotlight Russia is reportedly allowing China access to military training
-
Interpol arrests hundreds in Africa-wide sextortion crackdownIN THE SPOTLIGHT A series of stings disrupts major cybercrime operations as law enforcement estimates millions in losses from schemes designed to prey on lonely users